Recent News

• 06.12.2025 - Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon
• 04.09.2025 - IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
• 03.17.2025 - 37th Annual Roth Conference
• 03.17.2025 - 37th Annual Roth Conference
• 03.11.2025 - Prenetics to Participate in the 37th Annual ROTH Conference
• 03.05.2025 - Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
• 02.11.2025 - Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
• 01.21.2025 - Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham
• 01.15.2025 - Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials
• 01.15.2025 - Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Recent Filings

• 06.12.2025 - 6-K/A Report of foreign issuer [Rules 13a-16 and 15d-16]
• 06.12.2025 - EX-99.1 EX-99.1
• 06.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.07.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 04.30.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.05.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.05.2025 - EX-99.1 EX-99.1